Our second PME article discusses myocardial infarction (MI) (heart attacks) and stroke treatments, and how to use platelets to support precision medicine.
Patients who have recently suffered a heart attack or stroke are at high risk of recurrent events, but the commonly prescribed treatments are given in a ‘one size fits all’ approach, leaving many patients still at high risk in the future.
Testing platelet activity with TRIPLEcheck enables patient stratification to optimise treatments, thereby reducing recurrent events and improving patient outcomes.
This PME article discusses how TRIPLEcheck can be used to personalise medications and improve outcomes for patients with heart attack and stroke.
Read full article: https://pmlive.com/intelligence/optimised-therapy-to-improve-outcomes-for-heart-attack-and-stroke-patients/
